MRI Imaging Shows Changes to Heart Muscle in Some Patients on Ibrutinib for CLL and Other Blood Cancers
A newly published paper in JAMA Oncology found that among cancer patients with suspected ibrutinib-related cardiotoxic effects, the presence of heart muscle injury and scarring is high, and this is associated with an increased risk of developing future cardiovascular adverse events.